These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 24320203)
1. Assessment of sublingual misoprostol as first-line treatment for primary post-partum hemorrhage: results of a multicenter trial. Okonofua FE; Ogu RN; Akuse JT; Ujah IA; Galadanci HS; Fabamwo AO J Obstet Gynaecol Res; 2014 Mar; 40(3):718-22. PubMed ID: 24320203 [TBL] [Abstract][Full Text] [Related]
2. Rectally administrated misoprostol as an alternative to intravenous oxytocin infusion for preventing post-partum hemorrhage after cesarean delivery. Chaudhuri P; Mandi S; Mazumdar A J Obstet Gynaecol Res; 2014 Sep; 40(9):2023-30. PubMed ID: 25181622 [TBL] [Abstract][Full Text] [Related]
3. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. Winikoff B; Dabash R; Durocher J; Darwish E; Nguyen TN; León W; Raghavan S; Medhat I; Huynh TK; Barrera G; Blum J Lancet; 2010 Jan; 375(9710):210-6. PubMed ID: 20060161 [TBL] [Abstract][Full Text] [Related]
4. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan. Zuberi NF; Durocher J; Sikander R; Baber N; Blum J; Walraven G BMC Pregnancy Childbirth; 2008 Aug; 8():40. PubMed ID: 18718007 [TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomized controlled trial to explore oral tranexamic acid as adjunct for the treatment for postpartum hemorrhage. Diop A; Abbas D; Ngoc NTN; Martin R; Razafi A; Tuyet HTD; Winikoff B Reprod Health; 2020 Mar; 17(1):34. PubMed ID: 32143721 [TBL] [Abstract][Full Text] [Related]
6. Sublingual misoprostol for the prevention of postpartum hemorrhage. Al-Harazi AH; Frass KA Saudi Med J; 2009 Jul; 30(7):912-6. PubMed ID: 19618006 [TBL] [Abstract][Full Text] [Related]
7. Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind randomised controlled trial. Bellad MB; Tara D; Ganachari MS; Mallapur MD; Goudar SS; Kodkany BS; Sloan NL; Derman R BJOG; 2012 Jul; 119(8):975-82; discussion 982-6. PubMed ID: 22703421 [TBL] [Abstract][Full Text] [Related]
8. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. Blum J; Winikoff B; Raghavan S; Dabash R; Ramadan MC; Dilbaz B; Dao B; Durocher J; Yalvac S; Diop A; Dzuba IG; Ngoc NT Lancet; 2010 Jan; 375(9710):217-23. PubMed ID: 20060162 [TBL] [Abstract][Full Text] [Related]
9. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial. Atukunda EC; Siedner MJ; Obua C; Mugyenyi GR; Twagirumukiza M; Agaba AG PLoS Med; 2014 Nov; 11(11):e1001752. PubMed ID: 25369200 [TBL] [Abstract][Full Text] [Related]
10. Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial. Widmer M; Blum J; Hofmeyr GJ; Carroli G; Abdel-Aleem H; Lumbiganon P; Nguyen TN; Wojdyla D; Thinkhamrop J; Singata M; Mignini LE; Abdel-Aleem MA; Tran ST; Winikoff B Lancet; 2010 May; 375(9728):1808-13. PubMed ID: 20494730 [TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage. Al-Sawaf A; El-Mazny A; Shohayeb A J Obstet Gynaecol; 2013 Apr; 33(3):277-9. PubMed ID: 23550857 [TBL] [Abstract][Full Text] [Related]
12. [Reduced post-partum bleeding after treatment with sublingual misoprostol: a randomized double-blind clinical study in a developing country--secondary publication)]. Nielsen BB; Høj L; Hvidman LE; Nielsen J; Cardoso P; Aaby P Ugeskr Laeger; 2006 Mar; 168(13):1341-3. PubMed ID: 16579891 [TBL] [Abstract][Full Text] [Related]
13. A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage. Chaudhuri P; Majumdar A Int J Gynaecol Obstet; 2016 Feb; 132(2):191-5. PubMed ID: 26613819 [TBL] [Abstract][Full Text] [Related]
14. Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial. Owonikoko KM; Arowojolu AO; Okunlola MA J Obstet Gynaecol Res; 2011 Jul; 37(7):715-21. PubMed ID: 21375669 [TBL] [Abstract][Full Text] [Related]
15. Treatment for primary postpartum haemorrhage. Mousa HA; Blum J; Abou El Senoun G; Shakur H; Alfirevic Z Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD003249. PubMed ID: 24523225 [TBL] [Abstract][Full Text] [Related]
16. Misoprostol for the prevention and treatment of postpartum hemorrhage. Sheldon WR; Blum J; Durocher J; Winikoff B Expert Opin Investig Drugs; 2012 Feb; 21(2):235-50. PubMed ID: 22233426 [TBL] [Abstract][Full Text] [Related]
17. Rectal misoprostol versus intramuscular oxytocin for prevention of post partum hemorrhage. Shrestha A; Dongol A; Chawla CD; Adhikari RK Kathmandu Univ Med J (KUMJ); 2011; 9(33):8-12. PubMed ID: 22610801 [TBL] [Abstract][Full Text] [Related]
19. Treatment of postpartum hemorrhage with misoprostol. Blum J; Alfirevic Z; Walraven G; Weeks A; Winikoff B Int J Gynaecol Obstet; 2007 Dec; 99 Suppl 2():S202-5. PubMed ID: 17961565 [TBL] [Abstract][Full Text] [Related]
20. Initiating a novel therapy in preventing postpartum hemorrhage in rural India: a joint collaboration between the United States and India. Kodkany BS; Derman RJ; Goudar SS; Geller SE; Edlavitch SA; Naik VA; Patel A; Bellad MB; Patted SS Int J Fertil Womens Med; 2004; 49(2):91-6. PubMed ID: 15188836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]